Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udayan Chatterji

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Plos One|September 8, 2017
Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized micePhilippe A Gallay, Udayan Chatterji, Aaron Kirchhoff, et al.
Plos One|May 17, 2011
HSV neutralization by the microbicidal candidate C5ALot de Witte, Michael D Bobardt, Udayan Chatterji, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistanceUdayan Chatterji, Jose A Garcia-Rivera, James Baugh, et al.
The Journal of Biological Chemistry|July 18, 2012
Correlation between NS5A dimerization and hepatitis C virus replicationPrecious J Lim, Udayan Chatterji, Daniel Cordek, et al.
Virology|December 19, 2017
Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell cultureAdriaan H de Wilde, Jessika C Zevenhoven-Dobbe, Corrine Beugeling, et al.
Retrovirology|July 5, 2006
Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120James M Binley, Stacie Ngo-Abdalla, Penny Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2008
Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virusMichael D Bobardt, Guofeng Cheng, Lot de Witte, et al.
The Journal of Biological Chemistry|September 15, 2005
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifsAymeric de Parseval, Michael D Bobardt, Anju Chatterji, et al.
Journal of Hepatology|May 11, 2010
HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitorsUdayan Chatterji, Precious Lim, Michael D Bobardt, et al.
Plos One|November 10, 2010
DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5ALotte Coelmont, Xavier Hanoulle, Udayan Chatterji, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Plos One|September 8, 2017
Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized micePhilippe A Gallay, Udayan Chatterji, Aaron Kirchhoff, et al.
Plos One|May 17, 2011
HSV neutralization by the microbicidal candidate C5ALot de Witte, Michael D Bobardt, Udayan Chatterji, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistanceUdayan Chatterji, Jose A Garcia-Rivera, James Baugh, et al.
The Journal of Biological Chemistry|July 18, 2012
Correlation between NS5A dimerization and hepatitis C virus replicationPrecious J Lim, Udayan Chatterji, Daniel Cordek, et al.
Virology|December 19, 2017
Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell cultureAdriaan H de Wilde, Jessika C Zevenhoven-Dobbe, Corrine Beugeling, et al.
Retrovirology|July 5, 2006
Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120James M Binley, Stacie Ngo-Abdalla, Penny Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2008
Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virusMichael D Bobardt, Guofeng Cheng, Lot de Witte, et al.
The Journal of Biological Chemistry|September 15, 2005
A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifsAymeric de Parseval, Michael D Bobardt, Anju Chatterji, et al.
Journal of Hepatology|May 11, 2010
HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitorsUdayan Chatterji, Precious Lim, Michael D Bobardt, et al.
Plos One|November 10, 2010
DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5ALotte Coelmont, Xavier Hanoulle, Udayan Chatterji, et al.
Pageof 5